Standout Papers

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset... 1993 2026 2004 2015 6.9k
  1. Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families (1993)
    Elizabeth H. Corder, Ann M. Saunders et al. Science
  2. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. (1993)
    Warren J. Strittmatter, Ann M. Saunders et al. Proceedings of the National Academy of Sciences
  3. Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease (1993)
    Ann M. Saunders, Warren J. Strittmatter et al. Neurology
  4. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease (1994)
    Elizabeth H. Corder, Ann M. Saunders et al. Nature Genetics
  5. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. (1993)
    D. E. Schmechel, Ann M. Saunders et al. Proceedings of the National Academy of Sciences
  6. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. (1993)
    Warren J. Strittmatter, Karl H. Weisgraber et al. Proceedings of the National Academy of Sciences
  7. Patterns of Brain Activation in People at Risk for Alzheimer's Disease (2000)
    Susan Y. Bookheimer, Mark S. Cohen et al. New England Journal of Medicine
  8. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia (2003)
    Eric M. Reiman, Kewei Chen et al. Proceedings of the National Academy of Sciences
  9. Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways (2008)
    John Cogswell, James M. Ward et al. Journal of Alzheimer s Disease
  10. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease (2000)
    Gary W. Small, Linda M. Ercoli et al. Proceedings of the National Academy of Sciences
  11. Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease (2006)
    Marcus E. Risner, Ann M. Saunders et al. The Pharmacogenomics Journal
  12. Clinicopathologic Studies in Cognitively Healthy Aging and Alzheimer Disease (1998)
    Daniel W. McKeel, J. Philip Miller et al. Archives of Neurology

Immediate Impact

2 by Nobel laureates 52 from Science/Nature 255 standout
Sub-graph 1 of 11

Citing Papers

Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Disease-Associated Microglia: A Universal Immune Sensor of Neurodegeneration
2018 Standout
150 intermediate papers

Works of Ann M. Saunders being referenced

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
1993 Standout
Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
1993 StandoutScience
and 48 more

Author Peers

Author Last Decade Papers Cites
Ann M. Saunders 19328 11210 7812 176 30.9k
Allen D. Roses 17680 14249 5925 355 34.2k
Warren J. Strittmatter 14637 10653 4804 106 24.9k
Alison Goate 14754 12009 4096 426 29.7k
Suzanne Craft 12386 5696 4321 329 26.8k
Jeffery M. Vance 10173 12709 3577 290 28.5k
Peter St George‐Hyslop 16799 12247 3102 391 28.2k
Anne M. Fagan 14760 6030 9167 286 25.4k
Martin R. Farlow 12274 7832 6144 367 26.2k
Guojun Bu 14461 11785 2542 334 29.9k
D. E. Schmechel 12978 8082 4410 39 20.8k

All Works

Loading papers...

Rankless by CCL
2026